AARTI PHARMALABS Financial Statement Analysis
|
||
The Revenues of AARTI PHARMALABS have increased by 62.11% YoY .
The Earnings Per Share (EPS) of AARTI PHARMALABS has decreased by -99.56 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
AARTI PHARMALABS Last 5 Annual Financial Results
[BOM: 543748|NSE : AARTIPHARM]
Consolidated | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|
Revenues | ₹1,945 Cr | ₹1,200 Cr | ₹0.00 Cr |
Expenses | ₹1,603 Cr | ₹995 Cr | ₹0.01 Cr |
Operating Profit (Excl OI) | ₹342 Cr | ₹205 Cr | ₹-0.01 Cr |
Other Income | ₹2.32 Cr | ₹4.19 Cr | ₹0.00 Cr |
Interest | ₹21 Cr | ₹12 Cr | ₹0.00 Cr |
Depreciation | ₹63 Cr | ₹42 Cr | ₹0.00 Cr |
Profit Before Tax | ₹261 Cr | ₹155 Cr | ₹-0.01 Cr |
Profit After Tax | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr |
Consolidated Net Profit | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr |
Earnings Per Share (Rs) | ₹21.35 | ₹4,890.04 | ₹-0.18 |
PAT Margin (%) | 9.95 | 10.19 | 0.00 |
ROE(%) | 13.35 | 18.23 | -2.02 |
ROCE(%) | 16.11 | 19.40 | -1.87 |
Total Debt/Equity(x) | 0.14 | 0.25 | 0.08 |
Key Financials |
||
Market Cap | : | ₹ 5,494.0 Cr |
Revenue (TTM) | : | ₹ 1,852.6 Cr |
Net Profit(TTM) | : | ₹ 216.9 Cr |
EPS (TTM) | : | ₹ 23.9 |
P/E (TTM) | : | 25.3 |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI PHARMALABS | 20.2% | 31.8% | 43.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2% | -0.3% | 59.8% |
CIPLA | 6% | 2.8% | 50.4% |
DR REDDYS LABORATORIES | -1.3% | -2.8% | 31.5% |
ZYDUS LIFESCIENCES | 2.6% | 7.9% | 94.3% |
DIVIS LABORATORIES | 3.7% | 5.8% | 17.3% |
MANKIND PHARMA | -6.5% | -7.6% | 57% |
TORRENT PHARMACEUTICALS | 3.9% | 7.3% | 60.6% |
LUPIN | 3.2% | 3.3% | 111.9% |
AARTI PHARMALABS Revenues
[BOM: 543748|NSE : AARTIPHARM]
Y-o-Y | 62.11 % |
5 Yr CAGR | 0 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,945 Cr | 62.11 | |
Mar2022 | ₹1,200 Cr | 0 | |
Mar2021 | ₹0.00 Cr | - |
AARTI PHARMALABS Operating Profit
[BOM: 543748|NSE : AARTIPHARM]
Y-o-Y | 66.64 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹342 Cr | 66.64 | |
Mar2022 | ₹205 Cr | Positive | |
Mar2021 | ₹-0.01 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.75 % |
5 Yr CAGR | 0 |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 17.58% | 2.75 | |
Mar2022 | 17.11% | 0 | |
Mar2021 | 0% | - |
AARTI PHARMALABS Profit After Tax
[BOM: 543748|NSE : AARTIPHARM]
Y-o-Y | 58.28 % |
5 Yr CAGR | Positive |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹193 Cr | 58.28 | |
Mar2022 | ₹122 Cr | Positive | |
Mar2021 | ₹-0.01 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -2.36 % |
5 Yr CAGR | 0 |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 9.95 % | -2.36 | |
Mar2022 | 10.19 % | 0 | |
Mar2021 | 0 % | - |
AARTI PHARMALABS Earnings Per Share (EPS)
[BOM: 543748|NSE : AARTIPHARM]
Y-o-Y | -99.56 % |
5 Yr CAGR | Positive |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹21 | -99.56 | |
Mar2022 | ₹4,890 | Positive | |
Mar2021 | ₹-0.18 | - |
AARTI PHARMALABS Return on Capital Employed (ROCE)
[BOM: 543748|NSE : AARTIPHARM]
Y-o-Y | -16.96 % |
5 Yr CAGR | Positive |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 16.11% | -16.96 | |
Mar2022 | 19.4% | Positive | |
Mar2021 | -1.87% | - |
AARTI PHARMALABS Share Price vs Sensex
Current Share Price | : | ₹606.4 |
Current MarketCap | : | ₹ 5,494.0 Cr |
Updated EOD on | : | May 16,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 20.2% |
31.8% |
43.3% |
SENSEX | 1.7% |
-0.8% |
19% |
AARTI PHARMALABS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 4.2% | 2.3% | 58.4% |
S&P BSE MIDSMALLCAP | 4.1% | 2.9% | 59.6% |
S&P BSE HEALTHCARE | 3% | 0.4% | 52.9% |
S&P BSE ALLCAP | 3% | 1% | 36% |
You may also like the below Video Courses
FAQ about AARTI PHARMALABS Financials
How the annual revenues of AARTI PHARMALABS have changed ?
The Revenues of AARTI PHARMALABS have increased by 62.11% YoY .
How the Earnings per Share (EPS) of AARTI PHARMALABS have changed?
The Earnings Per Share (EPS) of AARTI PHARMALABS has decreased by -99.56 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs